Praxis Precision Medicines (PRAX) Non-Current Assets (2019 - 2026)

Praxis Precision Medicines' Non-Current Assets history runs 8 years deep, the most recent figure standing at $662.4 million for Q1 2026.

• In Q1 2026, Non-Current Assets rose 356.34% year-over-year to $662.4 million; the TTM figure through Mar 2026 stood at $1.3 billion (up 245.23% YoY), while the FY2025 annual figure was $327.0 million, up 315.3% from the prior year.
• Non-Current Assets was $662.4 million for Q1 2026 at Praxis Precision Medicines, up from $327.0 million in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $662.4 million in Q1 2026 to a low of $3.1 million in Q4 2023.
• Historically, Non-Current Assets has averaged $99.7 million across 5 years, with a median of $38.6 million in 2024.
• The sharpest annual moves came in 2023 and 2024: Non-Current Assets slipped 28.45% in 2023, then surged 2466.43% in 2024.
• A 5-year view of Non-Current Assets shows it stood at $4.3 million in 2022, then slipped by 28.45% to $3.1 million in 2023, then soared by 2466.43% to $78.7 million in 2024, then jumped by 315.3% to $327.0 million in 2025, then jumped by 102.58% to $662.4 million in 2026.
• The last three Non-Current Assets figures came in at $662.4 million (Q1 2026), $327.0 million (Q4 2025), and $122.5 million (Q3 2025), per Business Quant data.